Prevention

James S. Lewis, PharmD, FIDSA, explains why antimicrobial susceptibility testing is so important when it comes to stewardship programs.

Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.

Davey Legendre, PharmD, MBA, BCPS, sheds light on the prevalence of confirmed beta-lactam allergies in patients.

Updates to the EML highlight the dangerous growing threat of antimicrobial resistance and the dire situation we are currently facing.

Gonzalo Bearman, MD, MPH, explains when to prescribe antibiotics and suggests to pay attention to the data when it comes to length of treatment.

Superbugs, Zika, antibiotic development, C. difficile, and HIV are the article topics making up this week’s Top 5 articles.

Contagion® sat down with Rodrigo Mendes, PhD, to discuss research exploring evolving resistance among antibiotics to treat skin infections.

The weekly Business Watch includes the latest industry news that practitioners working in infectious diseases need to know.

Thomas File, MD, MSc explains what pleuromutilin antibiotics are and how they work.

Alan Gross, PharmD, BCPS-AQID, explains how antimicrobial stewardship programs need to be strengthened in long-term care facilities.

Incidence of superbug infections are certainly keeping the media in business, but is all the attention translating into an increased awareness of the importance of antibiotic stewardship?

New research suggests that making drug use a crime may negatively impact the prevention and treatment of HIV.

Prof. Josh Davis, MBBS, PhD, discusses the role of combination therapy when it comes to treating invasive Staphylococcus aureus infections.

Niaz Banaei, MD, discusses some reasons why healthcare-associated C. difficile tends to be over-diagnosed.

Romney Humphries, PhD, D(ABMM) sat down with Contagion® to discuss the process for receiving clearance on antimicrobial susceptibility tests in the United States.

At the recent ASM Microbe 2017 Conference, Contagion® sat down with David Hooper, MD, ASM Microbe Steering Committee Chair to learn more about his research.

Researchers from the University of Chicago are following the footprints of bacteria throughout a new hospital.

At the recent ASM Microbe 2017 Conference, Dr. Robert Bonomo shared with attendees highlights of his long-standing career and achievements.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing.

In case you missed them, here are our top 5 articles for the week of May 28, 2017.

Melissa B. Miller, PhD and Robin Patel, MD sat down with Contagion® to discuss how they believe that molecular-based point of care laboratory testing will revolutionize healthcare.

Milena McLaughlin, PharmD, MSc, explains the main causes of antimicrobial shortages.

Is it time to reassess prescribing practices on beta-lactams when it comes to patients with penicillin allergies? The answer is an unquestionable, “Yes!” according to Meghan Jeffres, PharmD.

Meghan Jeffres, PharmD, explains why practitioners need to think about the rate of cross-reactivity between antibiotic penicillin and specific cephalosporins.

Jerod Nagel, PharmD, highlights how rapid diagnostic tools can be utilized in antibiotic stewardship programs to improve outcomes for patients with S. aureus.

Conan MacDougall, PharmD, discusses how behavioral change interventions can positively impact the antibiotic prescribing environment.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains his team’s findings on the link between carbapenems and superinfections & Clostridium difficile.

The university reports that infection has subsided in several individuals; however, more people continue to report illness.

Lauri A. Hicks, DO, discusses keys to reducing antibiotic resistance.

Research presented at the 2017 American Thoracic Society International Conference reports that treatment with antibiotics failed in 1 in 4 adult patients who present with community-acquired pneumonia in the outpatient setting.